Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Voltage-Gated R-Type Calcium Channel Inhibition via Human μ-, δ-, and κ-opioid Receptors Is Voltage-Independently Mediated by Gβγ Protein Subunits

Géza Berecki, Leonid Motin and David J. Adams
Molecular Pharmacology January 2016, 89 (1) 187-196; DOI: https://doi.org/10.1124/mol.115.101154
Géza Berecki
Health Innovations Research Institute, RMIT University, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonid Motin
Health Innovations Research Institute, RMIT University, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David J. Adams
Health Innovations Research Institute, RMIT University, Melbourne, Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 89 no. 1 187-196
DOI 
https://doi.org/10.1124/mol.115.101154
PubMed 
26490245

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received July 30, 2015
  • Accepted October 19, 2015
  • Published online December 15, 2015.

Article Versions

  • Earlier version (October 21, 2015 - 07:55).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Géza Berecki,
  2. Leonid Motin, and
  3. David J. Adams1
  1. Health Innovations Research Institute, RMIT University, Melbourne, Victoria, Australia
  1. Address correspondence to:
    Géza Berecki, Health Innovations Research Institute, RMIT University, P.O. Box 71, Bundoora, Victoria 3083, Australia. E-mail: geza.berecki{at}rmit.edu.au
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: October 2015 to May 2023

AbstractFullPdf
Oct 2015120051
Nov 201593185
Dec 20152981762
Jan 20161752030
Feb 2016611016
Mar 2016671926
Apr 2016351417
May 201632923
Jun 20163165
Jul 20162123
Aug 201639310
Sep 20161765
Oct 20161796
Nov 20164336
Dec 20161567
Jan 201712413
Feb 201712110
Mar 20174238
Apr 201741610
May 20173226
Jun 20171177
Jul 20170209
Aug 201722017
Sep 201701413
Oct 201721811
Nov 201702711
Dec 201703419
Jan 20181287
Feb 20181237
Mar 201802415
Apr 20181237
May 201801916
Jun 201802014
Jul 20180165
Aug 201832214
Sep 20180197
Oct 20181438
Nov 201812614
Dec 201801916
Jan 201912115
Feb 201901812
Mar 201901414
Apr 201923019
May 201901612
Jun 201911619
Jul 201922221
Aug 201922619
Sep 201911412
Oct 201911323
Nov 201912338
Dec 201931712
Jan 202012322
Feb 202002612
Mar 202011921
Apr 202011320
May 2020316817
Jun 202041612
Jul 202021911
Aug 202043326
Sep 202013211
Oct 202014818
Nov 202061016
Dec 202061819
Jan 202133528
Feb 202132119
Mar 202142120
Apr 202131510
May 202152518
Jun 20212219
Jul 202111517
Aug 202121211
Sep 202131926
Oct 202102229
Nov 202101836
Dec 202151012
Jan 20223011
Feb 20224051
Mar 202225810
Apr 20221622
May 20224484
Jun 20223540
Jul 20223247
Aug 20221211
Sep 20223343
Oct 20223862
Nov 20222114
Dec 20221312
Jan 20233320
Feb 20231670
Mar 20232421
Apr 2023746
May 20232413

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 89 (1)
Molecular Pharmacology
Vol. 89, Issue 1
1 Jan 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Voltage-Gated R-Type Calcium Channel Inhibition via Human μ-, δ-, and κ-opioid Receptors Is Voltage-Independently Mediated by Gβγ Protein Subunits
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Cav2.3 Channel Inhibition via Opioid Receptor Activation

Géza Berecki, Leonid Motin and David J. Adams
Molecular Pharmacology January 1, 2016, 89 (1) 187-196; DOI: https://doi.org/10.1124/mol.115.101154

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Cav2.3 Channel Inhibition via Opioid Receptor Activation

Géza Berecki, Leonid Motin and David J. Adams
Molecular Pharmacology January 1, 2016, 89 (1) 187-196; DOI: https://doi.org/10.1124/mol.115.101154
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cysteine151 in Keap1 Drives CDDO-Me Pharmacodynamic Action
  • Allosteric Modulation of Metabotropic Glutamate Receptor 1
  • Mechanism of Selective Action of Paraherquamide A
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics